Transforming the Vaccine Manufacturing Chain
How Pharmaceutical Companies Can Ensure Quality and Accelerate Time to Market
Vaccine production concerns could be remedied and even avoided with faster, more efficient and precise quality procedures that improve their availability, efficacy, and safety. Yet with over 70% of manufacturing time spent on quality control, it takes many vaccines up to two years to get to market.In the eBook Transforming the Vaccine Manufacturing Chain: How Pharmaceutical Companies Can Ensure Quality and Accelerate Time to Market, InfinityQS looks at the variables inherent to vaccine production and how implementing a quality-centric approach could save your organization money, improve safety and efficiency, and decrease time to market.